Hologic Sales Drop In Q1 Despite Signs Of Capital-Equipment Market Recovery
This article was originally published in The Gray Sheet
Executive Summary
Women's health firm Hologic reported a 10% decline in its breast health unit quarterly sales compared to last year on Feb. 1, but a 2.5% sequential increase from the prior quarter, indicating that the market for large capital equipment may be stabilizing, the firm said